PlainRecalls
FDA Drug Critical Class I Terminated

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Reported: February 13, 2013 Initiated: December 18, 2012 #D-155-2013

Product Description

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Reason for Recall

Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.

Details

Recalling Firm
Matrixx Initiatives Inc
Units Affected
46,752 bottles
Distribution
Nationwide.
Location
Scottsdale, AZ

Frequently Asked Questions

What product was recalled?
Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.. Recalled by Matrixx Initiatives Inc. Units affected: 46,752 bottles.
Why was this product recalled?
Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 13, 2013. Severity: Critical. Recall number: D-155-2013.